| Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: An analysis of the surveillance, epidemiology, and end results database. | |
| | |
MedLine Citation:
|
PMID: 21365627 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Several trials have been conducted to determine the feasibility of preoperative radiotherapy (RT) for gastric cancer. However, the absolute benefit from radiotherapy remains to be defined. In this study, the authors examined the use of preoperative RT (Pre-RT) and postoperative RT (PORT) in patients with gastric cancer from the Surveillance, Epidemiology, and End Results (SEER) database. METHODS: The overall survival of patients who had nonmetastatic, resected gastric cancer between 2000 and 2006 was analyzed from the SEER database. Kaplan-Meier survival curves comparing Pre-RT, PORT, and no RT (No-RT) were analyzed using the log-rank test. A multivariate analysis (MVA) was conducted using Cox proportional hazards regression. RESULTS: The authors identified 10,251 patients. There was no survival benefit for patients who received Pre-RT or PORT compared with No-RT patients for the entire cohort. Conversely, among lymph node-positive patients, there was a significant survival benefit from both Pre-RT and PORT compared with No-RT (log-rank test: PORT, P < .0001; Pre-RT, P = .0261). The median survival and 5-year overall survival among lymph node-positive patients were 22 months and 24%, respectively, for Pre-RT;29 months and 34%, respectively, for PORT; and 19 months and 20%, respectively, for No-RT. MVA demonstrated that Pre-RT, PORT, and removing ≥15 lymph nodes were independent predictors of improved survival, whereas tumor classification, lymph node status, tumor size, and tumor location were independent predictors of death. CONCLUSIONS: The current results supported the use of Pre-RT in select patients with gastric cancer. However, additional trials will be needed to confirm these findings. Cancer 2011;. © 2011 American Cancer Society. |
| | |
Authors:
|
Ravi Shridhar; George W Dombi; Steven E Finkelstein; Kenneth L Meredith; Sarah E Hoffe |
Related Documents
:
|
62607 - Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients w... 21529987 - Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical bene... 21559977 - Postchemotherapy pet evaluation correlates with patient outcome in paediatric hodgkin's... 2104937 - Phase ii study of recombinant human interferon gamma for treatment of cutaneous t-cell ... 20719167 - Gene polymorphisms and chemotherapy in non-small cell lung cancer. 2917307 - High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-1 |
Journal Detail:
|
Title: Cancer Volume: - ISSN: 0008-543X ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0374236 Medline TA: Cancer Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 American Cancer Society. |
Affiliation:
|
Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida. ravi.shridhar@moffitt.org. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impact of post-therapy positron emission tomography on prognostic stratification and surveillance af...
Next Document: Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-base...